← Back to Search

Non-invasive Brain Stimulation

Active intermittent Theta Burst Stimulation for Attention Deficit Hyperactivity Disorder (ADHD)

N/A
Recruiting
Research Sponsored by Bradley Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up theta-gamma coupling will be obtained before the 1st session, and 24 hours after the 1st, 5th, and 10th sessions. statistical modeling will examine the change across these four time points. this change is considered a single primary outcome variable.
Awards & highlights

Study Summary

This trial will test if a non-invasive brain stimulation can help improve symptoms for adolescents with ADHD by changing how the brain works.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~adhd/working memory symptoms will be obtained before the 1st session, and 24 hours after the 1st, 5th, and 10th sessions. statistical modeling will examine the change across these time points. this change is considered a single primary outcome variable.
This trial's timeline: 3 weeks for screening, Varies for treatment, and adhd/working memory symptoms will be obtained before the 1st session, and 24 hours after the 1st, 5th, and 10th sessions. statistical modeling will examine the change across these time points. this change is considered a single primary outcome variable. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Parent-Reported ADHD & Working Memory-Related Symptoms
Change in Theta-Gamma Coupling
Change in Working Memory Test Performance

Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: Active intermittent Theta Burst StimulationActive Control1 Intervention
Participants will complete 10 daily sessions of active iTBS to the left dorsolateral prefrontal cortex
Group II: Sham intermittent Theta Burst StimulationPlacebo Group1 Intervention
Participants will complete 10 daily sessions of sham iTBS to the left dorsolateral prefrontal cortex

Find a Location

Who is running the clinical trial?

Bradley HospitalLead Sponsor
16 Previous Clinical Trials
1,469 Total Patients Enrolled
3 Trials studying Attention Deficit Hyperactivity Disorder (ADHD)
295 Patients Enrolled for Attention Deficit Hyperactivity Disorder (ADHD)

Media Library

Intermittent Theta Burst Stimulation to the Left Dorsolateral Prefrontal Cortex (Non-invasive Brain Stimulation) Clinical Trial Eligibility Overview. Trial Name: NCT05102864 — N/A
Attention Deficit Hyperactivity Disorder (ADHD) Research Study Groups: Sham intermittent Theta Burst Stimulation, Active intermittent Theta Burst Stimulation
Attention Deficit Hyperactivity Disorder (ADHD) Clinical Trial 2023: Intermittent Theta Burst Stimulation to the Left Dorsolateral Prefrontal Cortex Highlights & Side Effects. Trial Name: NCT05102864 — N/A
Intermittent Theta Burst Stimulation to the Left Dorsolateral Prefrontal Cortex (Non-invasive Brain Stimulation) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05102864 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the eligibility age for this research study limited to those under 35 years old?

"To be eligible for consideration, applicants must lie between 13 and 18 years of age. Data indicates that 98 trials are available to those younger than 18 while 28 clinical studies cater to the needs of individuals above 65."

Answered by AI

Is this research study open for recruitment at the present moment?

"Consistent with the data available on clinicaltrials.gov, this medical investigation is presently enrolling subjects. The study was first published on October 1st 2021 and its details were last modified on March 17th 2022."

Answered by AI

What criteria must potential participants meet to be eligible for this research?

"This clinical trial seeks 25 minors (ages 13-18) with a confirmed diagnosis of Attention Deficit Hyperactivity Disorder. In order to qualify, participants must be fluent in English and their parents or guardians must provide consent via assent. Furthermore, the BRIEF-2 Working Memory score should exceed 1 SD above normative mean and participants IQ needs to surpass 80. While medication for ADHD is allowed during study participation, no modifications can take place without physician approval; otherwise it may result in patient's withdrawal from the trial."

Answered by AI

How many volunteers have enrolled in this clinical experiment?

"Affirmative, the clinicaltrials.gov website reveals that this medical trial has been actively recruiting since October 1st 2021 and was revised on March 17th 2022. This study seeks 25 participants from a single venue."

Answered by AI

Who else is applying?

What state do they live in?
Massachusetts
How old are they?
< 18
What site did they apply to?
E. P. Bradley Hospital
What portion of applicants met pre-screening criteria?
Met criteria
~7 spots leftby Apr 2025